The Europe blood collection devices market is expected to grow from US$ 2,401.04 million in 2022 to US$ 3,827.75 million by 2030. It is estimated to grow at a CAGR of 6.0% from 2022 to 2030.
Surge in Demand for Minimally Invasive Diagnostic Tests Drives Europe Blood Collection Devices Market
Minimally invasive sampling techniques, such as capillary blood sampling, are routinely used for point-of-care testing in the home healthcare setting and clinical settings, such as the ICU, providing less pain and wounding than conventional venipuncture. There is a growing preference for minimally or non-invasive tests among patients for diagnostic purposes. Early cancer detection, tumor monitoring throughout treatment, mutation detection, and recurrence monitoring are possible using liquid biopsy and capillary blood sampling, which uses a non-invasive blood sample. Researchers can trace all genetic changes and epigenetics in solid tumors with a blood test, which is a simple and non-invasive technique. Patients select minimally invasive procedures for the advanced instruments used in the procedures, which allow for more complex and delicate work to be executed with less pain, lower risk, and less scarring.
Due to the advancements in technology in terms of feasibility and processing times, the blood collection procedure has recently attracted considerable interest as a non-invasive alternative. A blood test is a painless and non-invasive procedure that also reduces the cost and time it takes to diagnose a problem. A blood test is a simple alternative to surgical biopsies that allows doctors to discover information about tumors from a simple blood sample. Hence, the surge in demand for minimally invasive or non-invasive diagnostic tests fuels the Europe blood collection devices market growth.
Europe Blood Collection Devices Market Overview
The Europe blood collection devices market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany and France contribute significantly to the market in this region. The presence of prominent players and the prevalence of cardiovascular disease are the key factors driving the growth of the Europe blood collection devices market.
Europe Blood Collection Devices Market Revenue and Forecast to 2030 (US$ Million)
Europe Blood Collection Devices Market Segmentation
The Europe blood collection devices market is segmented into product type, methods, end user, and country.
Based on product type, the Europe blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the Europe blood collection devices market in 2022.
In terms of methods, the Europe blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the Europe blood collection devices market in 2022.
By end users, the Europe blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the Europe blood collection devices market in 2022.
Based on country, the Europe blood collection devices market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated Europe blood collection devices market in 2022.
Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, Greiner Bio One International GmBH, FL Medical SRL, and IntervacTechnology are some of the leading companies operating in the Europe blood collection devices market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 2,401.04 Million |
| Market Size by 2030 | US$ 3,827.75 Million |
| CAGR (2022 - 2030) | 6.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Blood Collection Devices Market is valued at US$ 2,401.04 Million in 2022, it is projected to reach US$ 3,827.75 Million by 2030.
As per our report Europe Blood Collection Devices Market, the market size is valued at US$ 2,401.04 Million in 2022, projecting it to reach US$ 3,827.75 Million by 2030. This translates to a CAGR of approximately 6.0% during the forecast period.
The Europe Blood Collection Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Blood Collection Devices Market report:
The Europe Blood Collection Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Blood Collection Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Blood Collection Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Europe Blood Collection Devices Market
